⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6888121 | 0.69 | — | — | |
| SCHEMBL7518548 | 0.67 | — | — | |
| SCHEMBL3259932 | 0.67 | — | — | |
| SCHEMBL9813262 | 0.67 | — | — | |
| SCHEMBL29098440 | 0.67 | — | — | |
| SCHEMBL8488894 | 0.67 | — | — | |
| SCHEMBL4853981 | 0.67 | — | — | |
| SCHEMBL10423895 | 0.67 | — | — | |
| SCHEMBL7974834 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL28898913 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116367815-A | Uv absorbing nanoparticles and microparticles for intradermal use | 科罗拉多大学董事会法人团体 | 2023-06-30 | — | — | CN | claimed |
| CN-117177989-A | Activity-inducible fusion proteins with heat shock protein 90 binding domain | 西雅图儿童医院以西雅图儿童研究机构名义经营 | 2023-12-05 | — | — | CN | disclosed |
| CN-116367815-A | Uv absorbing nanoparticles and microparticles for intradermal use | 科罗拉多大学董事会法人团体 | 2023-06-30 | — | — | CN | disclosed |
| CN-115996636-A | Methods and compositions for plywood products | 阿尔萨达股份公司 | 2023-04-21 | — | — | CN | disclosed |
| CN-114414707-B | Method and kit for detecting 19 drugs and metabolites thereof in blood by liquid chromatography tandem mass spectrometry | 北京和合医学诊断技术股份有限公司 | 2022-07-22 | — | — | CN | disclosed |
| CN-107083027-B | Oxazine resin composition, method for producing same, prepreg, laminate, and cured product | 日铁化学材料株式会社 | 2020-07-28 | — | — | CN | disclosed |
| CN-111032630-A | Compound, pharmaceutical composition, application and application thereof | 北京韩美药品有限公司 | 2020-04-17 | — | — | CN | disclosed |
| CN-106588937-B | Imidazopyrazines and its preparation method and application | 东莞市真兴贝特医药技术有限公司 | 2018-09-21 | — | — | CN | disclosed |
| CN-104583195-B | Nitrogenous heteroaromatic ring derivative as tyrosine kinase inhibitor | 山东亨利医药科技有限责任公司 | 2018-08-17 | — | — | CN | disclosed |
| CN-106588937-A | Imidazopyrazine compound, and preparation method and application thereof | 东莞市真兴贝特医药技术有限公司 | 2017-04-26 | — | — | CN | disclosed |
| US-6932961-B1 | Oxazinocarbazoles for the treatment of CNS diseases | PHARMACIA & UPJOHN COMPANY (US) | 2005-08-23 | — | — | US | disclosed |
| EP-1495031-A1 | LABELED OXAZINOCARBAZOLES AS DIAGNOSTIC AGENTS | Pharmacia & Upjohn Company LLC (US) | 2005-01-12 | — | — | EP | disclosed |
| US-6821970-B2 | USEFUL FOR TREATING DISEASES WHEREIN MODULATION OF 5-HT ACTIVITY IS DESIRED; NERVOUS SYSTEM DISORDERS | PHARMACIA & UPJOHN COMPANY | 2004-11-23 | — | — | US | disclosed |
| WO-2003089438-A1 | LABELED OXAZINOCARBAZOLES AS DIAGNOSTIC AGENTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2003-10-30 | — | — | WO | disclosed |
| EP-1200447-B1 | OXAZINOCARBAZOLES FOR THE TREATMENT OF CNS DISEASES | UPJOHN CO (US) | 2003-10-01 | — | — | EP | disclosed |
| US-20020169317-A1 | Oxazinocarbazoles for the treatment of CNS diseases | TENBRINK RUTH ELIZABETH (US) | 2002-11-14 | — | — | US | disclosed |
| US-6448397-B1 | TREATING CENTRAL NERVOUS SYSTEM DISEASES WITH MODULATION OF 5-HT ACTIVITY; ADRENERGIC, DOPAMINERGIC, AND SEROTONERGIC NEUROTRANSMITTERS; PSYCHOSIS, PARAPHRENIA, DEPRESSION, MANIA, SCHIZOPHRENIA, ANXIETY, MIGRAINE HEADACHE, DRUG ADDICTION | PHARMACIA & UPJOHN COMPANY | 2002-09-10 | — | — | US | disclosed |
| EP-1200447-A1 | OXAZINOCARBAZOLES FOR THE TREATMENT OF CNS DISEASES | PHARMACIA & UPJOHN COMPANY (US) | 2002-05-02 | — | — | EP | disclosed |
| WO-2001009142-A1 | OXAZINOCARBAZOLES FOR THE TREATMENT OF CNS DISEASES | PHARMACIA & UPJOHN COMPANY (US) | 2001-02-08 | — | — | WO | disclosed |
| US-5635608-A | CONTAINS PHOTOREMOVABLE ALPHA-CARBOXY-SUBSTITUTED ORTHO-NITROBENZYL GROUP THAT CHANGES THE FLUORESCENCE AND BIOLOGICAL PROPERTIES OF THE COMPOUND | MOLECULAR PROBES, INC. (US) | 1997-06-03 | — | — | US | disclosed |